Structure Therapeutics Inc. (GPCR)

NASDAQ: GPCR · IEX Real-Time Price · USD

37.44

-0.46 (-1.21%)

At close: Jul 19, 2024, 4:00 PM

37.82

+0.38 (1.01%)

Pre-market: Jul 22, 2024, 7:00 AM EDT

Structure Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Selling, General & Admin	37.49	32.67	16.37	8.59	3.54
Research & Development	77.65	70.1	36.19	29.11	12.36
Operating Expenses	115.14	102.78	52.56	37.7	15.91
Operating Income	-115.14	-102.78	-52.56	-37.7	-15.91
Other Expense / Income	-17.7	-13.39	-1.26	2.08	-0.17
Pretax Income	-97.44	-89.38	-51.3	-39.78	-15.74
Income Tax	0.24	0.24	0.02	0.23	0.14
Net Income	-97.68	-89.62	-51.32	-40.01	-15.88
Preferred Dividends	0	0	1.52	3.76	0.16
Net Income Common	-97.68	-89.62	-52.84	-43.77	-16.04
Shares Outstanding (Basic)	140	110	10	8	6
Shares Outstanding (Diluted)	140	110	10	8	6
Shares Change	94.98%	1049.81%	17.73%	30.01%	-
EPS (Basic)	-2.28	-2.43	-16.53	-16.14	-7.68
EPS (Diluted)	-2.28	-2.43	-16.53	-16.14	-7.68
Free Cash Flow	-95.59	-81.66	-46.28	-33.37	-14.3
Free Cash Flow Per Share	-2.05	-2.22	-14.48	-12.30	-6.85
EBITDA	-96.01	-88.46	-50.68	-39.51	-15.72
Depreciation & Amortization	1.44	0.93	0.62	0.27	0.02
EBIT	-97.44	-89.38	-51.3	-39.78	-15.74

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).